Evidence map›Paper›PMID 38328497›Full record

ArticleOpen forum infectious diseases2024

How to Detect Antibodies Against

Muyideen Kolapo Tijani, Joel Svensson, Paula Adlerborn, Lena Danielsson, Alexandra Teleka, Matilda Ljungqvist Lövmar, Per-Eric Lindgren, Pia Forsberg, Kristina E M Persson

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Human babesiosis: The past, present and future.Expert reviews in molecular medicine · 2025
    Review
  3. Article
  4. Research progress on diagnostic techniques for differentFrontiers in cellular and infection microbiology · 2025
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Muyideen Kolapo TijaniDepartment of Laboratory Medicine, Lund University, Lund, Sweden.
Joel SvenssonDepartment of Laboratory Medicine, Lund University, Lund, Sweden.
Paula AdlerbornDepartment of Laboratory Medicine, Lund University, Lund, Sweden.
Lena DanielssonDepartment of Laboratory Medicine, Lund University, Lund, Sweden.
Alexandra TelekaDepartment of Laboratory Medicine, Lund University, Lund, Sweden.
Matilda Ljungqvist LövmarDepartment of Clinical Microbiology, Region Jönköping County, Jönköping, Sweden.
Per-Eric LindgrenDepartment of Clinical Microbiology, Region Jönköping County, Jönköping, Sweden.
Pia ForsbergDivision of Infectious Diseases, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Kristina E M PerssonDepartment of Laboratory Medicine, Lund University, Lund, Sweden.ORCID https://orcid.org/0000-0003-2661-3115

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Today only indirect fluorescent antibody assays (IFAs) are commercially available to detect antibodies against Methods: Crude merozoite extract from in vitro cultures of a new Results: Using IFA as the reference method, the sensitivity and specificity of the ELISA were 86% (12/14) and 100% (52/52). There was a very high correlation ( Conclusions: This ELISA can detect antibodies directed against

Indexed as

antibodyBabesiablood transfusiondivergensELISA

Identifiers

PMID38328497
PMCPMC10849114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.